Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study

Ewa Wajs, A. Leah, Robert M. Morrison, Ella Daly, R. Lane, Pilar Lim, Richard Holder, Gerard Sanacora, Allan H. Young, Siegfried Kasper,

European Neuropsychopharmacology · 2019 · 17 citations · 0 references

Concepts